Table 5.
CYP | Type | Fitting | Cross-Validation | Test set | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
%na | NER | Sn | Sp | %na | NER | Sn | Sp | %na | NER | Sn | Sp | ||
3A4 | cons 1 | 33 | 0.88 | 0.92 | 0.84 | 33 | 0.88 | 0.92 | 0.84 | 36 | 0.88 | 0.92 | 0.83 |
cons 2 | - | 0.79 | 0.80 | 0.78 | - | 0.78 | 0.79 | 0.77 | 6 | 0.80 | 0.81 | 0.80 | |
2C9 | cons 1 | 33 | 0.89 | 0.90 | 0.88 | 34 | 0.89 | 0.90 | 0.88 | 40 | 0.89 | 0.89 | 0.88 |
cons 2 | - | 0.81 | 0.80 | 0.82 | - | 0.81 | 0.80 | 0.82 | 1 | 0.79 | 0.77 | 0.81 |